LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,834,000 | +6.6% | 11,422,000 | +2.2% | 0.38% | +3.0% |
| Q3 2020 | $10,165,000 | +10.0% | 11,178,000 | +6.4% | 0.37% | -10.2% |
| Q2 2020 | $9,240,000 | -16.9% | 10,506,000 | -21.8% | 0.41% | +10.5% |
| Q1 2020 | $11,123,000 | -44.9% | 13,431,000 | -42.4% | 0.37% | +9.1% |
| Q4 2019 | $20,189,000 | +3.5% | 23,325,000 | 0.0% | 0.34% | +19.6% |
| Q3 2019 | $19,499,000 | +17.0% | 23,325,000 | +21.2% | 0.28% | +50.0% |
| Q2 2019 | $16,668,000 | – | 19,250,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |